Hyeyoung Min

3.5k citations
80 papers · 2.8k indexed · 1 hit paper · h-index 22

Hyeyoung Min

76 papers receiving 2.7k citations

Hit Papers

miR-181a Is an Intrinsic Modulator of T Cell Sensitivity ...9732007202620132019250500750

Peers

Hyeyoung Min
Comparison fields: 5 of 143
  • Cancer Research 1.1k
  • Immunology 683
  • Pharmacology 280
  • Molecular Biology 1.8k
  • Complementary and alternative medicine 125
Replace Erguang Li with:
Erguang Li China
D. Haouzi France
Pei‐Wen Hsiao Taiwan
Santosh Kumar Singh India
Pijush K. Das India
Alejandro Garcı́a-Carrancá Mexico
Kasthuri Natarajan India
Changlin Zhou China
Fan Yang China
Xian‐Hui He China
Hyeyoung Min relative to Erguang Li China Erguang Li's profile →
Citations per field
00.5×2.6×
Erguang Li · 1×
Citations per year

Countries citing papers authored by Hyeyoung Min

Since Specialization
Citations

This map shows the geographic impact of Hyeyoung Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyeyoung Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyeyoung Min more than expected).

Fields of papers citing papers by Hyeyoung Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyeyoung Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyeyoung Min. The network helps show where Hyeyoung Min may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hyeyoung Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hyeyoung Min Line = papers co-authored together Hyeyoung Min links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20246
2 20240
3 202310
4 20232
5 20232
6 20213
7 202139
8 20181
9 201813
10 20179
11 201741
12 20173
13 201416
14 201420
15 2012280
16
Thymosin β4 expression correlates with lymph node metastasis through hypoxia inducible factor-α induction in breast cancer.
201118
17 201136
18 201018
19 200821
20 200517

About Hyeyoung Min

Hyeyoung Min is a scholar working on Cancer Research, Immunology and Pharmacology, having authored 80 papers that have together received 2.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), Immune Cell Function and Interaction (9 papers), Ginseng Biological Effects and Applications (9 papers), Cancer-related molecular mechanisms research (7 papers), Extracellular vesicles in disease (7 papers), RNA Interference and Gene Delivery (6 papers), RNA modifications and cancer (6 papers) and Natural product bioactivities and synthesis (6 papers). The work is most often cited by research in Cancer Research (1.1k citations), Immunology (683 citations) and Pharmacology (280 citations). Hyeyoung Min has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Soowon Kang, Chang‐Zheng Chen, Sungroh Yoon, Mark M. Davis, Ravi Braich, Muthiah Manoharan, Peter Ebert, Lawrence O. Klein, Kyungtaek Im and Jisu Kim. Their work appears in journals such as Cell, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026